Search | Page 6 | ASTRO

Survival (Time-To-Event) Curve Names and Endpoints
Gray Zone - Too Hot To Handle? Navigating the Dilemma of Radiation Necrosis after SRS for Brain Metastases
Unlocking the Radiosensitizing Potential of MYC inhibition in Neuroendocrine Malignancies
ROBIN Oligometastasis (OligoMET) Center: Using Biomarker Correlates from a Prostate Cancer Clinical Trial to Improve Future Outcomes
Techniques and Applications of Synthetic Images
Management of Locally Recurrent Head and Neck Cancer
2026 ASTRO Annual Refresher Course onDemand
The Journey of the Unknown Primary in the HPV Era: Evaluation, Treatment, Surveillance and Management of Oligometastatic Disease
2026 Multidisciplinary Head and Neck Cancers Symposium onDemand
Gray Zone - Management of Oligoprogression in the Thorax – Are We Making This Too Complicated?
Renal SABR: Implementation of A New Standard of Care
Providing Equitable Care to Pregnant Patients
Disparities in Gynecologic Cancer Care and Outcomes in the Age of Molecular Profiling and Targeted Therapies: Etiologies and Solutions
Palliative Radiation Therapy for Spine Metastases
Navigating the Complexities of Brain Metastases and Leptomeningeal Disease Management
New Tools for Formidable Foes: Strategies for Management of Unresected Soft Tissue Sarcomas
To Radiate or Not to Radiate? Updates to Management of Retroperitoneal Sarcoma
Radiation as an Immune Catalyst: Techniques, Biology and Biomaterials for Enhancing Tumor Control
Reirradiation with Stereotactic Body Radiation Therapy for Spinal Metastases: Planning Procedure from a High-Volume Multi-Disciplinary Spine Oncology Program (SOaR2)
ASTRO/KCA Joint Activity: Stereotactic Radiotherapy and Renal Cell Cancer, Overcoming Radioresistance and the Resistance to Radiate
A Systematic Review of Patient-Reported Outcomes on the Impact of Radiotherapy on Sexual Health in Gynecologic Cancer Patients
Gray Zone - Which Approach to SupPORT When the Nodes Don’t Get the Memo: Surprise pN2 Disease After Neoadjuvant Chemoimmunotherapy
Designing, Implementing and Interpreting Patient Reported Outcomes in Clinical Investigation
Contemporary Multi-Disciplinary Management of Bladder Cancer
Gray Zone - Scent of Doubt: The Dilemmas of Adjuvant Therapy in Esthesioneuroblastoma

Pages